How critical illness and physiologic stress alter thyroid tests, and how to avoid misdiagnosis in hospitalized patients.
Non-thyroidal illness syndrome (NTIS), sometimes called “euthyroid sick syndrome,” describes changes in thyroid function tests during systemic illness without intrinsic thyroid disease. The most common pattern is low total and free T3 due to reduced peripheral conversion of T4 to T3 and increased conversion to reverse T3. As illness severity increases, free T4 may decrease and TSH can be low, normal, or transiently elevated during recovery. These shifts can mimic hypothyroidism or hyperthyroidism, leading to inappropriate treatment if laboratory results are interpreted without clinical context.
Several mechanisms contribute, including altered deiodinase activity, changes in binding proteins, cytokine effects on the hypothalamic–pituitary axis, and medication influences. Glucocorticoids and dopamine can suppress TSH; iodinated contrast and amiodarone can complicate interpretation. Laboratory assay interference is also relevant, particularly high-dose biotin supplementation, which can produce spurious results in some immunoassays.
In stable outpatient settings, TSH is a robust screening test. In hospitalized or critically ill patients, testing should be reserved for situations where true thyroid disease is strongly suspected (e.g., myxedema coma, thyroid storm, unexplained arrhythmias with suggestive signs). When NTIS is likely, repeating tests after recovery is often the safest strategy. Current evidence does not support routine thyroid hormone therapy for NTIS outside of clinical trials, and management should focus on the underlying illness while monitoring for clinical signs that would justify targeted endocrine evaluation.
Several mechanisms contribute, including altered deiodinase activity, changes in binding proteins, cytokine effects on the hypothalamic–pituitary axis, and medication influences. Glucocorticoids and dopamine can suppress TSH; iodinated contrast and amiodarone can complicate interpretation. Laboratory assay interference is also relevant, particularly high-dose biotin supplementation, which can produce spurious results in some immunoassays.
In stable outpatient settings, TSH is a robust screening test. In hospitalized or critically ill patients, testing should be reserved for situations where true thyroid disease is strongly suspected (e.g., myxedema coma, thyroid storm, unexplained arrhythmias with suggestive signs). When NTIS is likely, repeating tests after recovery is often the safest strategy. Current evidence does not support routine thyroid hormone therapy for NTIS outside of clinical trials, and management should focus on the underlying illness while monitoring for clinical signs that would justify targeted endocrine evaluation.
Published February 11, 2026